FBI tipped off to risky experiments, which were funded by the agency headed by Dr. Anthony Fauci.
Experiments in China funded by the U.S. government could manipulate coronaviruses and leave no trace, according to newly disclosed emails.
Details of the experiments show that changing the viruses could be done and “would leave no signatures of purposeful human manipulation,” an unknown person told the FBI on April 23, 2020, according to one of the emails.
The details were outlined on a webpage for a grant funded by the U.S. National Institute of Allergy and Infectious Diseases, the agency headed by Dr. Anthony Fauci until late 2022. The government has funded $4.3 million for the grant. Some of the funds were sent to the Wuhan Institute of Virology, a laboratory located in the same Chinese city in which the first COVID-19 cases appeared in 2019.
An FBI official forwarded the email to another FBI official about an hour after receipt.
“Hey are you going to be in office tomorrow? We just interviewed our person from [redacted] again and he provided us with some alarming new info,” the official wrote. “Give me a call if you can.”
The identities of the source and FBI officials were redacted in the messages, which were obtained by the nonprofit Judicial Watch through a Freedom of Information Act request.
The FBI declined to comment. EcoHealth did not respond to a request for comment.
“These smoking gun documents showed the FBI quickly understood that Fauci’s agency funded the gain-of-function research that could disguise the resulting coronavirus as ‘natural,’” Judicial Watch President Tom Fitton said in a statement. “These new documents further demonstrate the need for a comprehensive criminal investigation into Fauci’s gain-of-function scandal.”
Robert Garry, who has a doctorate in microbiology and also studied virology, said in private messages that genetic manipulation doesn’t leave signatures. One could “synthesize bits of the genes … with perfect provision and then add them back in without a trace,” he wrote in early 2020 while analyzing COVID-19.
